<?xml version="1.0" encoding="UTF-8"?>
<p class="p">DHA and ARA in membrane phospholipids not only undergo metabolic turnover mediated by different phospholipases, but they are also linked to different downstream pathways providing eicosanoids which can be pro-inflammatory, and docosanoids which can be protective (
 <xref ref-type="fig" rid="metabolites-09-00040-f006" class="xref">Figure 6</xref>) [
 <xref rid="B34-metabolites-09-00040" ref-type="bibr" class="xref">34</xref>,
 <xref rid="B35-metabolites-09-00040" ref-type="bibr" class="xref">35</xref>,
 <xref rid="B36-metabolites-09-00040" ref-type="bibr" class="xref">36</xref>]. Studies using n-3 PUFA deficiency rats indicated the important role of DHA to alter glutamatergic and serotonergic systems and enhance proliferation of neurogenesis in offspring [
 <xref rid="B12-metabolites-09-00040" ref-type="bibr" class="xref">12</xref>]. In contrast to DHA, dietary supplementation of ARA was shown to cause an increase in inflammatory effects, including impairment of short-term memory and modifications of post-synaptic proteins [
 <xref rid="B37-metabolites-09-00040" ref-type="bibr" class="xref">37</xref>]. With the possibility that dietary DHA can attenuate neuroinflammatory responses, more studies are needed to test whether this dietary regimen also alters microglial cell function [
 <xref rid="B38-metabolites-09-00040" ref-type="bibr" class="xref">38</xref>,
 <xref rid="B39-metabolites-09-00040" ref-type="bibr" class="xref">39</xref>]. 
</p>
